The US Food and Drug Administration's (FDA) draft guidance aimed at speeding up and making less expensive biosimilar development is going to be a massive relief to Indian pharma and biotech companies.
.png "Lupin Launches VITALYFE to Transform Cardiometabolic Care")
Lupin Digital Health, India’s leading cardiac digital-therapeutics company, has launched VITALYFE, an AI-powered cardiometabolic wellness platform designed to help India’s professionals improve their heart health...
German inks and coatings leader Siegwerk has introduced a new range of mineral oil-free inks to India's pharmaceutical packaging sector, thus making a major move towards safer and more compliant packaging solutions.
AskBio, a fully owned and independently operated subsidiary of Bayer AG, has shared positive 12-month data from its Phase 1 clinical trial of AB-1002, an experimental gene therapy for congestive heart failure (CHF).
Eli Lilly and Company and Walmart Inc. have announced a new collaboration aimed at improving access to affordable obesity treatments
Shilpa Medicare, a full-service CDMO (Contract Development and Manufacturing Organization), has launched its new Flow Chemistry Centre of Excellence (CoE) at its Bengaluru site in Dobbespet, Avarahalli Industrial Area...
Medanta, one of India’s leading super-specialty healthcare providers, has taken a major step in advancing eye care with the launch of the UNITY Vitreoretinal Cataract System (VCS) at Medanta Mediclinic, Defence Colony, New Delhi...
The third-largest pharmaceutical business in India, Cipla, has finalized its long-discussed succession plan by confirming that Achin Gupta, its Global COO (GCOO), will be promoted to the position of Managing Director (MD) and Global CEO (GCEO) on
Roche today announced that it has been awarded CE mark for its Elecsys Dengue Ag test, a high-throughput, completely automated immunoassay intended to support the diagnosis of acute dengue virus infection. This achievement represents a...
India has increased its trade protection actions by broadening an anti-dumping probe concerning the import of Ethambutol Hydrochloride, which is a major one of the six essential active pharmaceutical ingredient
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")